Bryan Alexander
bryanidpharmd.bsky.social
Bryan Alexander
@bryanidpharmd.bsky.social
Infectious Disease, ASP, and OPAT Pharmacist at Nebraska Medicine
Reposted by Bryan Alexander
Evaluation of the safety of cefazolin monotherapy in outpatient parenteral antimicrobial therapy at a large academic medical center

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Kry6gk
October 3, 2025 at 8:53 PM
Reposted by Bryan Alexander
IDSA Foundation board member Dr. Jasmine Marcelin was in DC this week for #ALC54, an event hosted by the Congressional Black Caucus Foundation. Dr. Marcelin spoke on a panel, highlighting IDSA's efforts to diversify the ID workforce, advance health equity and expand access to care.
September 26, 2025 at 4:30 PM
Reposted by Bryan Alexander
Interested in learning about how a UTI order panel w/ clinical & laboratory reflex criteria can potentially impact UCx rates & CAUTIs? Join Esther Banker, PharmD & Yi Guo, PharmD, BCIDP from Montefiore Pharmacy residency in our latest SIDP Journal Club series (sidp.org/BCIDP), worth 1.5h of credit!
October 8, 2025 at 10:01 AM
Reposted by Bryan Alexander
Are you a trainee in Nebraska with an interest in Infectious Diseases?

Submit your research or interesting case report to the annual Nebraska ID Society meeting trainee abstract competition! #IDSky @unmccom.bsky.social

Learn more and submit your abstract here:
forms.office.com/r/69Q95n4KK9
Microsoft Forms
forms.office.com
March 6, 2025 at 7:44 PM
Reposted by Bryan Alexander
Congrats to Dr. Keintz, @bryanidpharmd.bsky.social, and Dr. Van Schooneveld on their recent publication in @ashejournal.bsky.social:

"Utility of urine culture in men with uncomplicated cystitis in ambulatory settings"

#IDSky #UTISky

www.cambridge.org/core/journal...
Utility of urine culture in men with uncomplicated cystitis in ambulatory settings | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Utility of urine culture in men with uncomplicated cystitis in ambulatory settings - Volume 5 Issue 1
www.cambridge.org
March 7, 2025 at 4:24 PM
Nice paper this week highlighting again the uselessness of serial ESR/CRP for many ID indications.

Really pleased to see an increasing focus in our OPAT community on diagnostic stewardship, working to decrease the number of unnecessary labs ordered, on behalf of both patients and OPAT personnel!
Evaluation of serial erythrocyte sedimentation rate and C-reactive protein monitoring in infectious disease outpatient parenteral antimicrobial therapy patients | Antimicrobial Stewardship & Healt...
Evaluation of serial erythrocyte sedimentation rate and C-reactive protein monitoring in infectious disease outpatient parenteral antimicrobial therapy patients - Volume 5 Issue 1
www.cambridge.org
March 6, 2025 at 12:56 PM
Reposted by Bryan Alexander
Dr. Keintz is interviewed in this @contagionlive.bsky.social article about her most recent paper in @ashejournal.bsky.social

Read the paper here:
www.cambridge.org/core/journal...

@bryanidpharmd.bsky.social #IDSky #UTISky
January 28, 2025 at 8:33 PM
Reposted by Bryan Alexander
@unmc.bsky.social ID: We describe the development and validation of an electronically-captured appropriate antibiotic use metric for ambulatory UTIs using coding data bit.ly/3Ws3Ogm
Development and validation of an antibiotic appropriateness metric for urinary tract infections and pyelonephritis in ambulatory settings | Antimicrobial Stewardship & Healthcare Epidemiology | Ca...
Development and validation of an antibiotic appropriateness metric for urinary tract infections and pyelonephritis in ambulatory settings - Volume 5 Issue 1
bit.ly
January 21, 2025 at 12:13 PM
Reposted by Bryan Alexander
Whelp. I decided to hop on the bandwagon & here I am!
January 15, 2025 at 5:57 PM
Reposted by Bryan Alexander
🆕💫Analysis of a collection of A. fumigatus from a global surveillance program:
Voriconazole has excellent parameters to be used as a surrogate for isavuconazole susceptibility in situations where isavuconazole susceptibility testing is not feasible
#idsky
journals.asm.org/doi/10.1128/...
December 21, 2024 at 6:38 PM